Search

everythinglearnresearchcommunity

for

Search:↓

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

PCOS is a condition causing irregular periods, excess male hormones, and infertility, often managed by targeting insulin resistance and specific symptoms.

Heat Shock Proteins are important in the development of Polycystic Ovarian Syndrome and could be targets for new treatments.

Environmental factors and chemicals might affect hormone balance and contribute to common hair loss.

Leydig cells can cause testosterone-secreting adrenal tumors in women.

Common skin conditions can greatly affect a person's mental health and social life.

Different causes of beard hair loss have various treatments, including medications, lifestyle changes, and procedures to stimulate hair growth.

Using scalp micropigmentation (a special tattoo technique) with hair transplantation can effectively treat hair loss, especially for those with low donor density or those unsuitable for only hair transplantation.

Most patients with PCOS were prescribed medroxyprogesterone acetate or oral contraceptives, with some experiencing side effects or needing prescription changes.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.

Zinc, copper, and iron are important for skin health and may help diagnose skin diseases.

Low zinc levels may contribute to hair loss due to increased oxidative DNA damage.

Lipid Accumulation Product and Free Androgens Index are effective for assessing fatty liver disease risk in women with Polycystic Ovary Syndrome.

Dutasteride works better than finasteride for hair loss, with both being safe to use.

The document sets criteria for diagnosing long-term sexual dysfunctions caused by certain medications.

Frontal fibrosing alopecia is a hair loss condition in postmenopausal women, similar to lichen planopilaris, with ineffective treatments.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

Evaluate postmenopausal women with high androgen levels using medical history, physical exams, lab tests, and imaging to manage health risks.

Postmenopausal frontal fibrosing alopecia is a type of hair loss in postmenopausal women that may stop on its own but has no effective treatment.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

Snail1 may contribute to fibrosis in frontal fibrosing alopecia in postmenopausal women.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

A woman developed male traits from accidental contact with her husband's testosterone gel.

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.

Ovariectomized mice mimic postmenopausal hair loss, and estradiol helps maintain hair density.

A postmenopausal woman's excess male hormone symptoms were caused by a rare adrenal gland tissue in her ovary.

Isoflavones may help with menopause symptoms but could be risky for women with hormone-sensitive cancers.

Postmenopausal women can experience hairline recession, affecting their quality of life, and more research is needed for treatments.

Over half of postmenopausal women experience hair loss, with severity increasing with age, time since menopause, and higher body mass index.

An 84-year-old woman's hair loss was due to a rare condition called Leydig cell hyperplasia, which was treated with surgery.